Lab testing is a cornerstone of healthcare. With 14 billion tests conducted annually in the U.S., it drives 70% of clinical decisions. As the healthcare industry shifts towards value-based care, unnecessary testing and high costs, particularly in genetic testing, pose issues.

In a recent Billing and Coding Magazine feature, Avalon CEO Bill Kerr, MD, shares how improved Lab Benefits Management provides the essential support needed in this shift, reducing reimbursement errors, providing health plans with increased cost control, improving patient outcomes, and reducing provider workloads—factors necessary in effectively achieving value-based care goals.

To access the full article, please visit Billing and Coding Magazine.